A Quantitative Promoter Methylation Profile of Prostate Cancer
Open Access
- 15 December 2004
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 10 (24) , 8472-8478
Abstract
Purpose: Promoter hypermethylation is an alternative pathway for gene silencing in neoplastic cells and a promising cancer detection marker. Although quantitative methylation-specific PCR (QMSP) of the GSTP1 promoter has demonstrated near perfect specificity for cancer detection in prostate biopsies, we postulated that identification and characterization of additional methylation markers might further improve its high (80–90%) sensitivity.Keywords
This publication has 27 references indexed in Scilit:
- QuantitativeRARβ2HypermethylationClinical Cancer Research, 2004
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Prognostic Factors for Multifocal Prostate Cancer in Radical Prostatectomy Specimens: Lack of Significance of Secondary CancersJournal of Urology, 2003
- Altered methylation of multiple genes in carcinogenesis of the prostateInternational Journal of Cancer, 2003
- Quantitative Gstp1 Methylation Clearly Distinguishes Benign Prostatic Tissue And Limited Prostate AdenocarcinomaJournal of Urology, 2003
- Pathological and clinical characteristics of large prostate cancers predominantly located in the transition zoneProstate Cancer and Prostatic Diseases, 2002
- CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter futureOncogene, 2002
- Emerging molecular markers of cancerNature Reviews Cancer, 2002
- Quantitative Assessment of Promoter Hypermethylation during Breast Cancer DevelopmentThe American Journal of Pathology, 2002
- LONG-TERM BIOCHEMICAL DISEASE-FREE AND CANCER-SPECIFIC SURVIVAL FOLLOWING ANATOMIC RADICAL RETROPUBIC PROSTATECTOMYUrologic Clinics of North America, 2001